BioAdaptives, Inc.
BDPT
$0.0257
$0.00124.90%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -90.99% | -98.11% | -55.44% | -21.34% | 173.08% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -90.99% | -98.11% | -55.44% | -21.34% | 173.08% |
| Cost of Revenue | 36.70% | 230.36% | 408.47% | 483.33% | 600.00% |
| Gross Profit | -494.95% | -747.20% | -809.17% | -910.87% | -252.31% |
| SG&A Expenses | 286.34% | 189.29% | 138.56% | 48.14% | 33.91% |
| Depreciation & Amortization | -96.52% | -100.00% | -93.26% | -122.42% | 334.85% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 215.11% | 163.97% | 131.64% | 49.34% | 63.41% |
| Operating Income | -254.20% | -201.62% | -155.13% | -58.69% | -55.58% |
| Income Before Tax | 0.87% | -7.86% | -26.19% | -68.38% | -4.81% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 0.87% | -7.86% | -26.19% | -68.38% | -4.81% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 0.87% | -7.86% | -26.19% | -68.38% | -4.81% |
| EBIT | -254.20% | -201.62% | -155.13% | -58.69% | -55.58% |
| EBITDA | -324.89% | -268.42% | -218.26% | -93.48% | -34.38% |
| EPS Basic | 33.01% | -15.05% | 37.44% | 46.23% | 82.38% |
| Normalized Basic EPS | 12.46% | -38.10% | 33.51% | 35.24% | 86.53% |
| EPS Diluted | 33.01% | -15.05% | 37.44% | 46.23% | 82.38% |
| Normalized Diluted EPS | 12.46% | -38.10% | 33.51% | 35.24% | 86.53% |
| Average Basic Shares Outstanding | 15.72% | -6.13% | 11.51% | 184.17% | 351.37% |
| Average Diluted Shares Outstanding | 15.72% | -6.13% | 11.51% | 184.17% | 351.37% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |